NaDeNo Gains Access to Nanopharmaceutical Development Services in 2nd Open Call
NaDeNo Nanoscience AS was selected to receive pro bono services to accelerate the development of their nanomedicine.
Read more
PHOENIX at PODD in Boston
PHOENIX was present at the Partnership Opportunities in Drug Delivery (PODD) in Boston from 28-29 October 2024.
PHOENIX booth at ECCPM Forum
PHOENIX will be at the ECCPM Forum, which welcomes attendees from diverse pharmaceutical organizations worldwide and features key note lectures…
Webinar on PHOENIX: A new player bridging nanopharmaceutical innovation from design to clinic
Want to hear more about PHOENIX services? Join our online introduction to the PHOENIX-OITB services on September 13th!
Apply for Funded Services in Nanopharmaceutical Innovation!
PHOENIX-OITB has launched the 2nd Round of its Open Call. First-stage applications are due 3 May 2024. Find out more…
Why a Single Entry Point for Nanopharmaceutical Innovation?
To introduce this new enterprise to potential customers, we sat down with PHOENIX-OITB gGmbH CEO Dr. Nazende Günday-Türeli to discuss…